Kaicai Liu

6PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 23, 2024
Deep Learning-Based Automatic Segmentation Combined with Radiomics to Predict Post-TACE Liver Failure in HCC Patients.

Shuai Li, Kaicai Liu, Chang Rong

|Nov 04, 2023
Liver abscess after drug-eluting bead transarterial chemoembolization for hepatic malignant tumors: Clinical features, pathogenesis, and management.

Li-Jun Wang, Liang Yin, Kai-Cai Liu

|Feb 23, 2023
Efficacy and Prognostic Factors of Regorafenib in the Treatment of BCLC Stage C Hepatocellular Carcinoma After Failure of the First-Line Therapy.

Beibei Xu, Dong Lu, Kaicai Liu

|Oct 07, 2022
Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation.

Liang Yin, Kai-Cai Liu, Wei-Fu Lv

|Oct 27, 2021
Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma.

Kai-Cai Liu, Wei-Fu Lv, Dong Lu

|Sep 09, 2020
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma.

Kai-Cai Liu, Ying-Hong Hao, Wei-Fu Lv

Pageof 1

Frequent Collaborators

2 joint publications

De-Lei Cheng

1 joint publications

Dong Lu